Nutt, David J.

Using [11C]Diprenorphine to Image Opioid Receptor Occupancy by Methadone in Opioid Addiction: Clinical and Preclinical Studies

Melichar, J. K., Hume, S. P., Williams, T. M., Daglish, M. R. C., Taylor, L. G., Ahmad, R., Malizia, A. L., Brooks, D. J., Myles, J. S., Lingford-Hughes, A., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics

Opioid Use Disorder TreatmentNeuropeptides and Animal Physiology

Cited by 71

Distinct Neuropsychological Mechanisms May Explain Delayed- Versus Rapid-Onset Antidepressant Efficacy

Stuart, S. A., Butler, P., Munafò, M. R., Nutt, D. J., & Robinson, E. S. (2015) · Neuropsychopharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 71

History of cannabis use is not associated with alterations in striatal dopamine D 2 /D 3 receptor availability

Stokes, P. R., Egerton, A., Watson, B., Reid, A., Lappin, J., Howes, O. D., Nutt, D. J., & Lingford-Hughes, A. R. (2012) · Journal of Psychopharmacology

Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on Behavior

Cited by 63

GABA A receptor availability is not altered in adults with autism spectrum disorder or in mouse models

Horder, J., Andersson, M., Mendez, M. A., Singh, N., Tangen, Ä., Lundberg, J., Gee, A., Halldin, C., Veronese, M., Bölte, S., et al. (2018) · Science Translational Medicine

Autism Spectrum Disorder ResearchNeuroscience and Neuropharmacology Research

Cited by 60

The Tangible Common Denominator of Substance Use Disorders: A Reply to Commentaries to Rehm et al. (2013a)

Rehm, J., Anderson, P., Gual, A., Kraus, L., Marmet, S., Nutt, D. J., Room, R., Samokhvalov, A. V., Scafato, E., Shield, K. D., et al. (2014) · Alcohol and Alcoholism

Substance Abuse Treatment and OutcomesGambling Behavior and Treatments

Cited by 56

Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?

Carhart-Harris, R. L., Wagner, A. C., Agrawal, M., Kettner, H., Rosenbaum, J. F., Gazzaley, A., Nutt, D. J., & Erritzoe, D. (2022) · Journal of Psychopharmacology

Psychedelics and Drug StudiesDigital Mental Health Interventions

Cited by 51

A point mutation in the ion conduction pore of AMPA receptor GRIA3 causes dramatically perturbed sleep patterns as well as intellectual disability

Davies, B., Brown, L. A., Cais, O., Watson, J., Clayton, A. J., Chang, V. T., Biggs, D., Preece, C., Hernandez-Pliego, P., Krohn, J., et al. (2017) · Human Molecular Genetics

Sleep and Wakefulness ResearchCircadian rhythm and melatonin

Cited by 48

Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals

Livingston, N. R., Calsolaro, V., Hinz, R., Nowell, J., Raza, S., Gentleman, S., Tyacke, R. J., Myers, J., Venkataraman, A. V., Perneczky, R., et al. (2022) · Molecular Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 44

Biological Markers of Generalized Anxiety Disorder

Maron, E., & Nutt, D. (2018) · Focus

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Cited by 42

Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy men

Wilson, S., Højer, A.-M., Buchberg, J., Areberg, J., & Nutt, D. J. (2015) · Journal of Psychopharmacology

Treatment of Major DepressionSleep and related disorders

Cited by 32

Antidepressants, withdrawal, and addiction; where are we now?

Jauhar, S., Hayes, J., Goodwin, G. M., Baldwin, D. S., Cowen, P. J., & Nutt, D. J. (2019) · Journal of Psychopharmacology

Treatment of Major DepressionSubstance Abuse Treatment and Outcomes

Cited by 31

Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood

Wilson, S. J., Bailey, J. E., Alford, C., Weinstein, A., & Nutt, D. J. (2002) · Journal of Psychopharmacology

Sleep and related disordersSleep and Wakefulness Research

Cited by 30

Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers

Wilson, S. J., Bailey, J. E., Alford, C., & Nutt, D. J. (2000) · Journal of Psychopharmacology

Sleep and related disordersSleep and Work-Related Fatigue

Cited by 24

The effect of diazepam on indices of 5-HT function in man

Nutt, D. J., Cowen, P. J., Franklin, M., Murdock, P., Gosden, B., & Fraser, S. (1986) · Pharmacology Biochemistry and Behavior

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 14

Imaging and genetic approaches to inform biomarkers for anxiety disorders, obsessive-compulsive disorders, and PSTD

Maron, E., Lan, C.-C., & Nutt, D. (2018) · Current Topics in Behavioral Neurosciences

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Cited by 9

Visual mismatch negativity in Parkinson's psychosis and potential for testing treatment mechanisms

Vignando, M., ffytche, D., Mazibuko, N., Palma, G., Montagnese, M., Dave, S., Nutt, D. J., Gabay, A. S., Tai, Y. F., Batzu, L., et al. (2024) · Brain Communications

Hallucinations in medical conditionsParkinson's Disease Mechanisms and Treatments

Cited by 6